Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

For more information about Stargaze, visit www.stargazestage.com.

Discover how a pioneering program is revolutionizing access to preventative care and empowering advisors to deepen client ...